Non-Natural and Photo-Reactive Amino Acids as Biochemical Probes of Immune Function

被引:11
作者
Gomez-Nunez, Marta [1 ]
Haro, Kurtis J. [1 ,2 ]
Dao, Tao [1 ]
Chau, Deming [1 ,2 ]
Won, Annie [1 ,2 ]
Escobar-Alvarez, Sindy [1 ,2 ]
Zakhaleva, Victoriya [1 ]
Korontsvit, Tatyana [1 ]
Gin, David Y. [1 ]
Scheinberg, David A. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10021 USA
[2] Weill Cornell, Grad Sch Med Sci, New York, NY USA
关键词
D O I
10.1371/journal.pone.0003938
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Wilms tumor protein (WT1) is a transcription factor selectively overexpressed in leukemias and cancers; clinical trials are underway that use altered WT1 peptide sequences as vaccines. Here we report a strategy to study peptide-MHC interactions by incorporating non-natural and photo-reactive amino acids into the sequence of WT1 peptides. Thirteen WT1 peptides sequences were synthesized with chemically modified amino acids (via fluorination and photo-reactive group additions) at MHC and T cell receptor binding positions. Certain new non-natural peptide analogs could stabilize MHC class I molecules better than the native sequences and were also able to elicit specific T-cell responses and sometimes cytotoxicity to leukemia cells. Two photo-reactive peptides, also modified with a biotin handle for pull-down studies, formed covalent interactions with MHC molecules on live cells and provided kinetic data showing the rapid clearance of the peptide-MHC complex. Despite "infinite affinity'' provided by the covalent peptide bonding to the MHC, immunogenicity was not enhanced by these peptides because the peptide presentation on the surface was dominated by catabolism of the complex and only a small percentage of peptide molecules covalently bound to the MHC molecules. This study shows that non-natural amino acids can be successfully incorporated into T cell epitopes to provide novel immunological, biochemical and kinetic information.
引用
收藏
页数:9
相关论文
共 39 条
[1]   BIOSYNTHETIC SITE-SPECIFIC INCORPORATION OF A NON-NATURAL AMINO-ACID INTO A POLYPEPTIDE [J].
BAIN, JD ;
GLABE, CG ;
DIX, TA ;
CHAMBERLIN, AR ;
DIALA, ES .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1989, 111 (20) :8013-8014
[2]   Two distinct HLA-A0201-presented epitopes of the Wilms tumor antigen can function as targets for leukemia-reactive CTL [J].
Bellantuono, I ;
Gao, LQ ;
Parry, S ;
Marley, S ;
Dazzi, F ;
Apperley, J ;
Goldman, JM ;
Stauss, HJ .
BLOOD, 2002, 100 (10) :3835-3837
[3]   The Wilms' tumor gene is frequently expressed in acute myeloblastic leukemias and may provide a marker for residual blast cells detectable by PCR [J].
Brieger, J ;
Weidmann, E ;
Maurer, U ;
Hoelzer, D ;
Mitrou, PS ;
Bergmann, L .
ANNALS OF ONCOLOGY, 1995, 6 (08) :811-816
[4]   ISOLATION AND CHARACTERIZATION OF A ZINC FINGER POLYPEPTIDE GENE AT THE HUMAN CHROMOSOME-11 WILMS TUMOR LOCUS [J].
CALL, KM ;
GLASER, T ;
ITO, CY ;
BUCKLER, AJ ;
PELLETIER, J ;
HABER, DA ;
ROSE, EA ;
KRAL, A ;
YEGER, H ;
LEWIS, WH ;
JONES, C ;
HOUSMAN, DE .
CELL, 1990, 60 (03) :509-520
[5]   Significant correlation between the degree of WT1 expression and the International Prognostic Scoring System score in patients with myelodysplastic syndromes [J].
Cilloni, D ;
Gottardi, E ;
Messa, F ;
Fava, M ;
Scaravaglio, P ;
Bertini, M ;
Girotto, M ;
Marinone, C ;
Ferrero, D ;
Gallamini, A ;
Levis, A ;
Saglio, G .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (10) :1988-1995
[6]   Synthetic anticancer vaccine candidates: Rational design of antigenic peptide mimetics that activate tumor-specific T-cells [J].
Douat-Casassus, Celine ;
Marchand-Geneste, Nathalie ;
Diez, Elisabeth ;
Gervois, Nadine ;
Jotereau, Francine ;
Quideau, Stephane .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (07) :1598-1609
[7]   In vitro stimulation with WT1 peptide-loaded Epstein-Barr virus-positive B cells elicits high frequencies of WT1 peptide-specific T cells with in vitro and in vivo tumoricidal activity [J].
Doubrovina, ES ;
Doubrovin, MM ;
Lee, S ;
Shieh, JH ;
Heller, G ;
Pamer, E ;
O'Reilly, RJ .
CLINICAL CANCER RESEARCH, 2004, 10 (21) :7207-7219
[8]   Selective elimination of leukemic CD34+ progenitor cells by cytotoxic T lymphocytes specific for WT1 [J].
Gao, LQ ;
Bellantuono, I ;
Elsässer, A ;
Marley, SB ;
Gordon, MY ;
Goldman, JM ;
Stauss, HJ .
BLOOD, 2000, 95 (07) :2198-2203
[9]   Peptide binding motif predictive algorithms correspond with experimental binding of leukemia vaccine candidate peptides to HLA-A*0201 molecules [J].
Gomez-Nunez, Marta ;
Pinilla-Ibarz, Javier ;
Dao, Tao ;
May, Rena J. ;
Pao, Mary ;
Jaggi, Jaspreet S. ;
Scheinberg, David A. .
LEUKEMIA RESEARCH, 2006, 30 (10) :1293-1298
[10]   Partially modified retro-inverso pseudopeptides as non-natural ligands for the human class I histocompatibility molecule HLA-A2 [J].
Guichard, G ;
Connan, F ;
Graff, R ;
Ostankovitch, M ;
Muller, S ;
Guillet, JG ;
Choppin, J ;
Briand, JP .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (10) :2030-2039